Insight of a Metabolic Prognostic Model to Identify Tumor Environment and Drug Vulnerability for Lung Adenocarcinoma

Insight of a Metabolic Prognostic Model to Identify Tumor Environment and Drug Vulnerability for Lung Adenocarcinoma

Metabolic reprogramming is a novel method for the treatment of malignant tumors. The exploration of metabolism procedures between radiosensitive and radioresistant tumors may provide novel perspectives for lung adenocarcinoma (LUAD) patients after radiation therapy. In our study, metabolic reprogram...

Full description

Bibliographic Details
Main Authors: Shun-Li Peng, Rong Wang, Yu-Ling Zhou, Wei Wei, Gui-Hua Zhong, Xiao-Tao Huang, Shuai Yang, Qiao-Dan Liu, Zhi-Gang Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Immunology
Subjects:
metabolic signature
prognostic model
radiosensitivity
immune response
non-small cell lung cancer
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.872910/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.872910/full

Similar Items